Challenges of PK/PD measurements in modern drug development (Q34975033)

5 August 2017

1 reference

title

Challenges of PK/PD measurements in modern drug development (English)

1 reference

5 August 2017

Workman P

1

1 reference

5 August 2017

1 November 2002

1 reference

European Journal of Cancer

5 August 2017

1 reference

5 August 2017

38

1 reference

5 August 2017

16

1 reference

5 August 2017

2189-2193

1 reference

Discovering novel chemotherapeutic drugs for the third millennium

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900395-7

7 January 2021

Scoring a bull's-eye against cancer genome targets

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900395-7

7 January 2021

Mechanism-based target identification and drug discovery in cancer research

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900395-7

7 January 2021

Initial sequencing and analysis of the human genome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900395-7

7 January 2021

The Sequence of the Human Genome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900395-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900395-7

1 reference

7 January 2021

Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900395-7

7 January 2021

Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperone.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900395-7

7 January 2021

Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900395-7

7 January 2021

HIF-1 and tumor progression: pathophysiology and therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900395-7

7 January 2021

The relationship between tumour oxygenation determined by oxygen electrode measurements and magnetic resonance spectroscopy of the fluorinated 2-nitroimidazole SR-4554.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900395-7

7 January 2021

HSP90 as a new therapeutic target for cancer therapy: the story unfolds

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900395-7

7 January 2021

Hsp90 inhibitors as novel cancer chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900395-7

7 January 2021

The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900395-7

7 January 2021

10.1016/S0959-8049(02)00395-7

Identifiers

DOI

1 reference

release_56trw2cxcfeg7pcdsmeo4l5nr4

5 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/56trw2cxcfeg7pcdsmeo4l5nr4

24 November 2022

mapped directly with Wikidata item

PubMed ID

12387843

1 reference

PubMed ID

12387843